Atlas Trials

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours

Clinical trial NCT03770234 · COMPLETED

Trial details

NCT number
NCT03770234
Sponsor
Grünenthal GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PainPharmacokinetics
Start date
2004-04-05
Primary completion
2004-05-26
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.